CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Viemed Healthcare Inc   (VMD)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

VMD's Net Income Growth by Quarter and Year

Viemed Healthcare Inc 's Net Income results by quarter and year




VMD Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 3.48 2.44 4.09
III Quarter September - 2.92 1.06 1.79
II Quarter June 1.48 2.33 0.97 1.57
I Quarter March 1.60 1.52 1.76 1.68
FY   3.08 10.25 6.23 9.13



VMD Net Income second quarter 2024 Y/Y Growth Comment
Viemed Healthcare Inc reported fall in Net Income in the second quarter 2024 by -36.61% to $ 1.48 millions, from the same quarter in 2023.
The drop in the second quarter 2024 Viemed Healthcare Inc 's Net Income compares unfavorably to the Company's average Net Income fall of -14.78%.

Looking into second quarter 2024 results within Healthcare Facilities industry 9 other companies have achieved higher Net Income growth. While Viemed Healthcare Inc ' s Net Income drop of -36.61% ranks overall at the positon no. 383 in the second quarter 2024.


VMD Net Income ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - 42.62 % -40.34 % -19.33 %
III Quarter September - 175.47 % -40.78 % -36.07 %
II Quarter June -36.61 % 140.21 % -38.22 % -91.91 %
I Quarter March 5.26 % -13.64 % 4.76 % -60.38 %
FY   - 64.53 % -31.76 % -71.03 %

Financial Statements
Viemed Healthcare Inc 's second quarter 2024 Net Income $ 1.48 millions VMD's Income Statement
Viemed Healthcare Inc 's second quarter 2023 Net Income $ 2.33 millions Quarterly VMD's Income Statement
New: More VMD's historic Net Income Growth >>


VMD Net Income (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - 19.18 % 130.19 % 128.49 %
III Quarter September - 25.32 % 9.28 % 14.01 %
II Quarter June -7.69 % 53.29 % -44.89 % -6.55 %
I Quarter March -54.02 % -37.7 % -56.97 % -66.86 %
FY (Year on Year)   - 64.53 % -31.76 % -71.03 %


Compare VMD Profitability >> Back to VMD Growth rate Comparisons >>


Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #10
Healthcare Sector #41
Overall #383

Net Income Y/Y Growth Statistics
High Average Low
72.81 % -14.78 % -71.06 %
(Mar 31 2024)   (Dec 31 2021)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #10
Healthcare Sector #41
Overall #383
Net Income Y/Y Growth Statistics
High Average Low
72.81 % -14.78 % -71.06 %
(Mar 31 2024)   (Dec 31 2021)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Viemed Healthcare Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
357.51 % 26.96 % -85.56 %
(Jun 30 2020)  


VMD's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2024 Viemed Healthcare Inc reported drop in Net Income from the previous quarter by -7.69% to $ 1.48 millions, from $ 1.60 millions achived a quarter before.

Although cyclical influence usually energize II. Quarter 2024 performance, it clearly was not enough to recover Viemed Healthcare Inc 's performance, Liam Reed, a business contributor wrote.

Within Healthcare Facilities industry 10 other companies have achieved higher Net Income quarter on quarter growth. While Viemed Healthcare Inc 's Net Income growth quarter on quarter, overall rank is 885.


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #59
Overall #885
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #59
Overall #885
Net Income Q/Q Growth Statistics
High Average Low
357.51 % 26.96 % -85.56 %
(Jun 30 2020)  


VMD's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2024 Viemed Healthcare Inc disclosed drop in Net Income from the first quarter by -7.69% to $ 1.48 millions, from $ 1.60 millions achived in the previous quarter.

Even seasonal circumstance were not able to rescue the II. Quarter for the Viemed Healthcare Inc , Liam Reed, a business contributor pointed out, he voiced little caution towards VMD's perspective, he detected further headwinds onward for Viemed Healthcare Inc .

Within Healthcare Facilities industry 10 other companies have achieved higher Net Income quarter on quarter growth. While Viemed Healthcare Inc 's Net Income growth quarter on quarter, overall rank is 885.


Viemed Healthcare Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Net Income 12 Months Ending $ 9.48 $ 10.33 $ 10.24 $ 9.20 $ 7.34
Y / Y Net Income Growth (TTM) 29.1 % 72.81 % 64.63 % 16.94 % -14.7 %
Year on Year Net Income Growth Overall Ranking # 791 # 1164 # 1004 # 1407 # 1260
Seqeuential Net Income Change (TTM) -8.26 % 0.84 % 11.29 % 25.4 % 22.8 %
Seq. Net Income Growth (TTM) Overall Ranking # 383 # 770 # 909 # 1193 # 1024

New: More VMD's historic Net Income Growth >>



Cumulative Net Income growth Comment
Assuming the Viemed Healthcare Inc 's fiscal year would have ended in Jun 30 2024, Viemed Healthcare Inc would have reprted above average annual Net Income rise of 29.1% year on year, of $ 9 millions.
This marks a slow-down of the companys growth trends and from the 72.81% increase in Mar 31 2024.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 791, from total ranking in previous quarter at 1164.

Net Income TTM Q/Q Growth Statistics
High Average Low
72.81 %
-14.78 %
-71.06 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 10
Healthcare Sector # 59
Overall # 791

Net Income TTM Y/Y Growth Statistics
High Average Low
72.81 %
-14.78 %
-71.06 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 41
S&P 500 # 383
Cumulative Net Income growth Comment
Assuming the Viemed Healthcare Inc 's fiscal year would have ended in Jun 30 2024, Viemed Healthcare Inc would have reprted above average annual Net Income rise of 29.1% year on year, of $ 9 millions.
This marks a slow-down of the companys growth trends and from the 72.81% increase in Mar 31 2024.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 791, from total ranking in previous quarter at 1164.

Net Income TTM Q/Q Growth Statistics
High Average Low
72.81 %
-14.78 %
-71.06 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 10
Healthcare Sector # 59
Overall # 791

Net Income TTM Y/Y Growth Statistics
High Average Low
72.81 %
-14.78 %
-71.06 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 41
S&P 500 # 383




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
VMD's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for VMD's Competitors
Net Income Growth for Viemed Healthcare Inc 's Suppliers
Net Income Growth for VMD's Customers

You may also want to know
VMD's Annual Growth Rates VMD's Profitability Ratios VMD's Asset Turnover Ratio VMD's Dividend Growth
VMD's Roe VMD's Valuation Ratios VMD's Financial Strength Ratios VMD's Dividend Payout Ratio
VMD's Roa VMD's Inventory Turnover Ratio VMD's Growth Rates VMD's Dividend Comparisons



Companies with similar Net Income increase for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions
Option Care Health Inc -53.63%$ -53.635 millions
Pro dex Inc -58.30%$ -58.303 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com